BA
ALBO

BlackRock Advisors’s Albireo Pharma Inc ALBO Stock Holding History

BlackRock Advisors’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-193
Closed -$13K – 3739
2014
Q2 		$13K Hold
193
– – ﹤0.01% 3534
2014
Q1 		$16K Buy
193
+84
+77% +$7.64K ﹤0.01% 3465
2013
Q4 		$7K Hold
109
– – ﹤0.01% 3551
2013
Q3 		$10K Buy
109
+30
+38% +$3.91K ﹤0.01% 3466
2013
Q2 		$10K Buy
+79
New +$8.22K ﹤0.01% 3421

Other funds holding ALBO

BC
Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FNYS
First New York Securities New York $53.5M AUM 57.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return